FierceBiotech ٢٣ فبراير ٢٠٢٦ UPDATED: FDA illuminates new approval pathway for bespoke gene editing therapies
FierceBiotech ١٤ يناير ٢٠٢٦ JPM26: Illumina working with China on 'a path through' its export troubles, sees academic research environment 'muted' for '26
FierceBiotech ٩ يناير ٢٠٢٦ Quanterix nabs Illumina’s CCO as new leader, but Leerink warns of ‘significant lift’ needed for turnaround
FierceBiotech ٩ يناير ٢٠٢٦ Illumina hires former NHGRI Director Eric Green as new chief medical officer